Establishment of optimized in vitro assay methods for evaluating osteocyte functions

Journal of Bone and Mineral Metabolism

Volumn 33, Issue 1, 2015, Pages 73-84

  Honma, Masashi ^a   Ikebuchi, Yuki ^a   Kariya, Yoshiaki ^a   Suzuki, Hiroshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Co culture system; Culture method; Differentiation; Osteoclastogenesis; Osteocyte

Indexed keywords

ACID PHOSPHATASE; COLLAGEN; CULTURE MEDIUM; DMP1 PROTEIN, MOUSE; DRUG COMBINATION; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; GLYCOPROTEIN; GP38 PROTEIN, MOUSE; ISOENZYME; LAMININ; MATRIGEL; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEOGLYCAN; SCLEROPROTEIN; SOST PROTEIN, MOUSE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFSF11 PROTEIN, MOUSE;

ANIMAL; BONE MARROW CELL; BOVINE; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; COCULTURE; CONFOCAL MICROSCOPY; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DENDRITIC CELL; DRUG COMBINATION; MACROPHAGE; METABOLISM; MOUSE; NEWBORN; OSTEOCYTE; SERUM;

ACID PHOSPHATASE; ANIMALS; ANIMALS, NEWBORN; BONE MARROW CELLS; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; COLLAGEN; CULTURE MEDIA; DENDRITIC CELLS; DRUG COMBINATIONS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLAST GROWTH FACTORS; GLYCOPROTEINS; ISOENZYMES; LAMININ; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; OSTEOCYTES; PROTEOGLYCANS; RANK LIGAND; SERUM;

EID: 84891079409     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-013-0555-5     Document Type: Article

References (24)

1. Bonewald LF, Johnson ML (2008) Osteocytes, mechanosensing and Wnt signaling. Bone 42:606–615
2. Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 26:229–238
3. Cheng F, Hulley P (2010) The osteocyte—a novel endocrine regulator of body phosphate homeostasis. Maturitas 67:327–338
4. Dewitt DD, Kaszuba SN, Thompson DM, Stegemann JP (2009) Collagen I-Matrigel scaffolds for enhanced Schwann cell survival and control of three-dimensional cell morphology. Tissue Eng Part A 15:2785–2793
5. Fukunaga T, Kurata K, Matsuda J, Higaki H (2008) Effects of strain magnitude on mechanical responses of three-dimensional gel-embedded osteocytes studied with a novel 10-well elastic chamber. J Biomech Sci Eng 3:13–24
6. Gu G, Nars M, Hentunen TA, Metsikko K, Vaananen HK (2006) Isolated primary osteocytes express functional gap junctions in vitro. Cell Tissue Res 323:263–271
7. Hauschka PV, Chen TL, Mavrakos AE (1988) Polypeptide growth factors in bone matrix. Ciba Found Symp 136:207–225
8. Honma M, Ikebuchi Y, Kariya Y, Hayashi M, Hayashi N, Aoki S et al (2013) RANKL subcellular trafficking and regulatory mechanisms in osteocytes. J Bone Miner Res 28:1936–1949
9. Karsdal MA, Larsen L, Engsig MT, Lou H, Ferreras M, Lochter A et al (2002) Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J Biol Chem 277:44061–44067
10. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF (1997) Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 12:2014–2023
11. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR (1982) Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188–6193
12. Kurata K, Fukunaga T, Matsuda J, Higaki H (2007) Role of mechanically damaged osteocytes in the initial phase of bone remodeling. Int J Fatigue 29:1010–1018
13. Li X, Udagawa N, Takami M, Sato N, Kobayashi Y, Takahashi N (2003) p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 144:4999–5005
14. Lind M (1996) Growth factors: possible new clinical tools: a review. Acta Orthop 67:407–417
15. Liu S, Gupta A, Quarles LD (2007) Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329–335
16. McNamara LM, Majeska RJ, Weinbaum S, Friedrich V, Schaffler MB (2009) Attachment of osteocyte cell processes to the bone matrix. Anat Rec (Hoboken) 292:355–363
17. Moester MJ, Papapoulos SE, Lowik CW, van Bezooijen RL (2010) Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 87:99–107
18. Mulcahy LE, Taylor D, Lee TC, Duffy GP (2011) RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone 48:182–188
19. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ et al (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17:1231–1234
20. ten Dijke P, Krause C, de Gorter DJ, Lowik CW, van Bezooijen RL (2008) Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am 90 Suppl 1:31–35
21. Torreggiani E, Matthews BG, Pejda S, Matic I, Horowitz MC, Grcevic D, Kalajzic I (2013) Preosteocytes/osteocytes have the potential to dedifferentiate becoming a source of osteoblasts. PLoS One 8:e75204
22. van Bezooijen RL, Svensson JP, Eefting D, Visser A, van der Horst G, Karperien M et al (2007) Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. J Bone Miner Res 22:19–28
23. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’Brien CA (2011) Matrix-embedded cells control osteoclast formation. Nat Med 17:1235–1241
24. Yang W, Harris MA, Heinrich JG, Guo D, Bonewald LF, Harris SE (2009) Gene expression signatures of a fibroblastoid preosteoblast and cuboidal osteoblast cell model compared to the MLO-Y4 osteocyte cell model. Bone 44:32–45